FDA grants accelerated approval to Biogen treatment for rare form of ALS By: MarketWatch April 25, 2023 at 14:47 PM EDT The FDA has deemed Biogen's torferson reasonably likely to produce a clinical benefit for patients. Read More >> Related Stocks: Biogen Idec Ionis Pharmaceuticals
